Evidence map›Paper›PMID 29270469›Full record

ReviewJournal of current ophthalmology2017

Updates on corneal collagen cross-linking: Indications, techniques and clinical outcomes.

Mehrdad Mohammadpour, Ahmad Masoumi, Masoud Mirghorbani, Kianoosh Shahraki, Hassan Hashemi

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of current ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Regenerative therapy · 2025
    Article
  5. Article
  6. The impact of interrupted corneal collagen crosslinking (CXL) treatment.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. The Underlying Relationship between Keratoconus and Down Syndrome.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mehrdad MohammadpourEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ahmad MasoumiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Masoud MirghorbaniEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Kianoosh ShahrakiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hassan HashemiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRFarabi Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review the historical background and basic principles of collagen cross-linking, to bring together the data regarding the outcomes and complications of collagen cross-linking and finally to explore the efficacy and safety of new variations of this technique.

methodsA literature review was performed using PubMed and Scopus. The following keywords were used for literature search: cross linking, crosslinking, cross-linking, keratoconus, keratectasia.

resultsIn contrast to traditional treatment modalities for keratoconus (KCN), this new technique addresses the progression of the disease. Several clinical studies have been conducted to assess the efficacy of corneal collagen cross-linking (CXL) in the last decade. The results were promising as collagen cross-linking showed significant improvement in visual acuity and keratometric values. Moreover, initial results show that it is a safe procedure with few reported complications.

conclusionCXL is an emerging treatment method in ophthalmology that offers the possibility to effectively treat progressive KCN.

Indexed as

Corneal collagen cross-linkingKeratoconusSafety and efficacy

Identifiers

PMID29270469
PMCPMC5735256
OpenAlexW2754159973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.